These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 22275851

  • 1. NMDA receptors and fear extinction: implications for cognitive behavioral therapy.
    Davis M.
    Dialogues Clin Neurosci; 2011; 13(4):463-74. PubMed ID: 22275851
    [Abstract] [Full Text] [Related]

  • 2. Reconsolidation and extinction of conditioned fear: inhibition and potentiation.
    Lee JL, Milton AL, Everitt BJ.
    J Neurosci; 2006 Sep 27; 26(39):10051-6. PubMed ID: 17005868
    [Abstract] [Full Text] [Related]

  • 3. Effects of D-cycloserine on extinction: translation from preclinical to clinical work.
    Davis M, Ressler K, Rothbaum BO, Richardson R.
    Biol Psychiatry; 2006 Aug 15; 60(4):369-75. PubMed ID: 16919524
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Astrocytic NMDA Receptors in the Basolateral Amygdala Contribute to Facilitation of Fear Extinction.
    Shelkar GP, Liu J, Dravid SM.
    Int J Neuropsychopharmacol; 2021 Nov 12; 24(11):907-919. PubMed ID: 34363482
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Neurobiology of anxiety disorders and implications for treatment.
    Garakani A, Mathew SJ, Charney DS.
    Mt Sinai J Med; 2006 Nov 12; 73(7):941-9. PubMed ID: 17195879
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Role of NMDA receptors and MAP kinase in the amygdala in extinction of fear: clinical implications for exposure therapy.
    Davis M.
    Eur J Neurosci; 2002 Aug 12; 16(3):395-8. PubMed ID: 12193180
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Targeting the NMDA receptor for fear-related disorders.
    Amaral OB, Roesler R.
    Recent Pat CNS Drug Discov; 2008 Nov 12; 3(3):166-78. PubMed ID: 18991806
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Potentiation of GluN2C/D NMDA receptor subtypes in the amygdala facilitates the retention of fear and extinction learning in mice.
    Ogden KK, Khatri A, Traynelis SF, Heldt SA.
    Neuropsychopharmacology; 2014 Feb 12; 39(3):625-37. PubMed ID: 24008353
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Role of the amygdala in fear extinction measured with potentiated startle.
    Davis M, Walker DL, Myers KM.
    Ann N Y Acad Sci; 2003 Apr 12; 985():218-32. PubMed ID: 12724161
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.